Amy Edmonds
Keine laufenden Positionen mehr
Profil
Amy Edmonds worked as the Head of Clinical Operations at Celgene Corp.
from 2002 to 2012.
She also worked as the Secretary and VP of Clinical Operations & Administration at Bellerophon Therapeutics, Inc. Additionally, she received an undergraduate degree from the University of Richmond.
Ehemalige bekannte Positionen von Amy Edmonds
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01.10.2012 |
| BELLEROPHON THERAPEUTICS, INC. | Verwaltungsdirektor | - |
Ausbildung von Amy Edmonds
| University of Richmond | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
